• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口腔棘细胞癌晚期的多学科治疗。初步结果]

[Multidisciplinary treatment in advanced stages of spinocellular carcinoma of the oral cavity. Initial results].

作者信息

Pomatto E, Berutto M, Falco V, Vercellino V

机构信息

Università degli Studi di Torino, Istituto Policattedra di Clinica Odontostomatologica.

出版信息

Minerva Chir. 1994 May;49(5):437-40.

PMID:7970042
Abstract

As in almost all forms of tumour, the best therapeutic results for those of the oral cavity is obtained following the first treatment which must be incisive and appropriate because it often represents the sole decisive possibility of recovery. In advanced forms (stages III and IV) it is best to establish a close collaboration between surgeon, cancer specialist and radiotherapist: this paper reports the authors' experience over the past 5 years with regard to advanced stages of spinocellular carcinoma of the oral cavity treated according to a chemoradiosurgical therapeutic protocol. Of the 134 cases treated by our unit, 77 were included in the protocol showing a 78% actuarial survival rate over 40 months.

摘要

与几乎所有类型的肿瘤一样,口腔肿瘤患者在首次治疗后能取得最佳治疗效果,首次治疗必须精准且恰当,因为这往往是康复的唯一决定性机会。对于晚期(III期和IV期)病例,最好由外科医生、癌症专家和放疗师密切协作:本文报告了作者在过去5年中,按照放化疗手术治疗方案,对晚期口腔棘细胞癌的治疗经验。在我们科室治疗的134例病例中,77例纳入该方案,其40个月的精算生存率为78%。

相似文献

1
[Multidisciplinary treatment in advanced stages of spinocellular carcinoma of the oral cavity. Initial results].[口腔棘细胞癌晚期的多学科治疗。初步结果]
Minerva Chir. 1994 May;49(5):437-40.
2
Stage IV oral cavity carcinoma. Is conventional radical treatment an option?IV期口腔癌。传统根治性治疗是一种选择吗?
Saudi Med J. 2002 Sep;23(9):1095-8.
3
The prognostic significance of histological features in oral squamous cell carcinoma.口腔鳞状细胞癌组织学特征的预后意义
J Oral Pathol Med. 2009 Sep;38(8):657-62. doi: 10.1111/j.1600-0714.2009.00797.x. Epub 2009 Jun 25.
4
Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.T3-4期口腔癌的动脉内放化疗:与口咽癌和下咽癌相比的治疗结果
World J Surg Oncol. 2008 Jan 14;6:2. doi: 10.1186/1477-7819-6-2.
5
[Current trends in the therapy of spinocellular carcinoma of the oral cavity].[口腔鳞状细胞癌治疗的当前趋势]
Minerva Stomatol. 1987 May;36(5):381-7.
6
[Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].[口腔、咽和喉恶性肿瘤——症状、诊断与治疗]
Ther Umsch. 1998 Jul;55(7):449-52.
7
Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.复发性口腔和口咽鳞状细胞癌新分期系统的开发
Cancer. 1999 Oct 15;86(8):1387-95.
8
[Extracapsular lymph node metastasis in squamous cell carcinoma of the oral cavity after chemo-radio-surgical treatment protocol].[口腔鳞状细胞癌经放化疗-手术治疗方案后的囊外淋巴结转移]
Minerva Chir. 1994 Jun;49(6):565-8.
9
Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.口腔鳞状细胞癌的生存率:pT4 N0与其他IVA期分类之间的差异。
Cancer. 2007 Aug 1;110(3):564-71. doi: 10.1002/cncr.22814.
10
[The potentials for optimizing the treatment of III-stage squamous cell cancer of the oral mucosa].[口腔黏膜III期鳞状细胞癌治疗优化的潜力]
Vopr Onkol. 1990;36(10):1251-5.